Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 2 completed trials

    Completion Rate
    100%(2/2)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 1
    2
    67%
    Phase 2
    1
    33%

    Phase Distribution

    2

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Phase 1Safety & dosage
    2(66.7%)
    Phase 2Efficacy & side effects
    1(33.3%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    2 of 2 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(2)
    Other(1)

    Detailed Status

    Completed2
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 12 (66.7%)
    Phase 21 (33.3%)

    Trials by Status

    unknown133%
    completed267%

    Recent Activity

    0 active trials
    Showing 3 of 3
    unknownphase_2

    Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring

    NCT03762382
    completedphase_1

    Safety, PK, and PD Study of IVRs Releasing TFV and LNG

    NCT03279120
    completedphase_1

    Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone

    NCT02235662

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT03762382Phase 2

    Tenofovir/Levonorgestrel Intravaginal Ring and Tenofovir Intravaginal Ring

    Unknown
    NCT03279120Phase 1

    Safety, PK, and PD Study of IVRs Releasing TFV and LNG

    Completed
    NCT02235662Phase 1

    Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    3